MAPS Act

The MAPS Act requires the U.S. Department of Health and Human Services (HHS) to create and maintain a list of essential medicines critical for responding to public health emergencies or preventing shortages that threaten healthcare systems. It mandates HHS to map the entire U.S. supply chain for these listed drugs - including tracking production locations, volumes, and regulatory actions - using data analytics to identify vulnerabilities. The law establishes a confidential database for this purpose, with HHS required to submit annual reports to Congress on progress and supply chain gaps. This directly affects pharmaceutical manufacturers, healthcare providers, and patients by improving federal visibility into drug supply chains to prevent shortages during crises.